Suchergebnisse - "Ohtake, Shigeki"

PubPharm (212)

1

Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission

enthalten in: American journal of hematology | 2024

von Nishiwaki, S. | Sugiura, I. | Fujisawa, S. | +17

2

Real-world data of MDS and CMML in Japan : results of JALSG clinical observational study-11 (JALSG-CS-11)

enthalten in: International journal of hematology | 2024

von Usuki, K. | Ohtake, S. | Honda, S. | +27

3

Real-world data of AML in Japan : results of JALSG clinical observational study-11 (JALSG-CS-11)

enthalten in: International journal of hematology | 2024

von Usuki, K. | Ohtake, S. | Honda, S. | +27

4

Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study : The JALSG-CS11-MDS-SCT

enthalten in: Annals of hematology | 2024

von Nakagawa, N. | Ishiyama, K. | Usuki, K. | +23

5

Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission

enthalten in: American Journal of Hematology | 2024

von Nishiwaki, S. | Sugiura, I. | Fujisawa, S. | +16

6

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms

enthalten in: Blood advances | 2023

von Nannya, Y. | Tobiasson, M. | Sato, S. | +35

7

High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia : JALSG Ph+ALL TKI-SCT Study

enthalten in: HemaSphere | 2023

von Nishiwaki, S. | Sugiura, I. | Fujisawa, S. | +17

8

Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes : a JALSG MDS212 trial

enthalten in: International journal of hematology | 2022

von Miyazaki, Y. | Kiguchi, T. | Sato, S. | +43

9

Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial

enthalten in: International journal of hematology | 2022

von Miyazaki, Y. | Kiguchi, T. | Sato, S. | +26

10

Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial

enthalten in: International journal of hematology | 2022

von Miyazaki, Y. | Kiguchi, T. | Sato, S. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]